Alzchem Group AG

Alzchem Group AG's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Alzchem Group AG has 10.12M shares outstanding.

As of June 30, 2026, Alzchem Group AG maintains a current ratio of 2.70, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.18, indicating elevated leverage, while an interest coverage ratio of 23.43 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Alzchem Group AG posted a return on equity (ROE) of 27.32, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 24.70 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.94, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 24.32, useful for judging operating efficiency across full business cycles. The company generates approximately 331,529.45 in revenue per employee across its workforce of 1,761.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.54 indicates how many times Alzchem Group AG sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Alzchem Group AG recorded 25.50M in income tax expense. That works out to an effective tax rate of 27.43, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 92.99M, leaving 67.31M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Over the twelve months ended June 30, 2026, Alzchem Group AG generated 584.07M in revenue and converted that into 67.31M in net income, yielding earnings per share of 6.67. EBITDA reached 128.67M, while operating income came in at 100.85M.

As of June 30, 2026, Alzchem Group AG holds 65.70M in cash and equivalents against 90.22M in total debt, resulting in a net debt position of 22.30M. Total book value stands at 269.90M, with working capital of 194.30M providing operational flexibility.

Alzchem Group AG produced 93.94M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -27.39M in capital expenditures, free cash flow totaled 66.55M - equivalent to 6.58 per share.

Over the twelve months ended June 30, 2026, Alzchem Group AG posted a gross margin of 70.68, reflecting its pricing power and cost economics. The operating margin of 17.27 and net profit margin of 11.52 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Alzchem Group AG paid dividends of 3.90 per share. The dividend payout ratio of 58.31 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Alzchem Group AG's most recent stock split took place on July 1, 2019 with a 10:1 split ratio.